Teachers Advisors’s ImmunityBio IBRX Stock Holding History

Teachers Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$88K	Hold	55,383	–	–	﹤0.01%	2945
2018 Q4	$64K	Hold	55,383	–	–	﹤0.01%	2976
2018 Q3	$205K	Sell	55,383 -582	-1%	-$1.84K	﹤0.01%	2937
2018 Q2	$171K	Hold	55,965	–	–	﹤0.01%	3015
2018 Q1	$218K	Hold	55,965	–	–	﹤0.01%	2861
2017 Q4	$251K	Buy	55,965 +5	+0%	+$24	﹤0.01%	2872
2017 Q3	$307K	Hold	55,960	–	–	﹤0.01%	2821
2017 Q2	$425K	Buy	55,960 +15,453	+38%	+$66.8K	﹤0.01%	2669
2017 Q1	$144K	Hold	40,507	–	–	﹤0.01%	2930
2016 Q4	$232K	Buy	40,507 +14,131	+54%	+$94.3K	﹤0.01%	2864
2016 Q3	$205K	Hold	26,376	–	–	﹤0.01%	2878
2016 Q2	$164K	Buy	26,376 +19,656	+293%	+$153K	﹤0.01%	2962
2016 Q1	$55K	Hold	6,720	–	–	﹤0.01%	3002
2015 Q4	$116K	Hold	6,720	–	–	﹤0.01%	2999
2015 Q3	$77K	Buy	+6,720	New	+$147K	﹤0.01%	3040

Other funds holding IBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Teachers Advisors's IBRX Position: Q1 2019 in Review

Teachers Advisors held its ImmunityBio (IBRX) position steady in Q1 2019 at 55,383 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

Teachers Advisors first reported a position in IBRX in Q3 2015 and has held it in 15 quarters since. The position peaked at $425K in Q2 2017. 58 funds tracked by Wall St. Rank hold IBRX as of Q1 2019.

Teachers Advisors held 55,383 shares of ImmunityBio worth $88K as of Q1 2019.
Teachers Advisors left its ImmunityBio share count unchanged in Q1 2019.
ImmunityBio made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2945 holding.
Teachers Advisors first reported a position in ImmunityBio in Q3 2015 and has held it in 15 quarters since.
Teachers Advisors's ImmunityBio position peaked at $425K in Q2 2017.
58 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.